BRAFv600E mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma

被引:8
|
作者
Jing Fan-jing [1 ]
Liang Jun [1 ]
Liang Zhi-yong [2 ]
Meng Chao [1 ]
Long Wen [3 ]
Li Xiao-yi [4 ]
Lin Yan-song [3 ]
机构
[1] Qingdao Univ, Qingdao Med Coll, Affiliated Hosp, Dept Oncol, Qingdao 266003, Shandong, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
[4] Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
papillary thyroid carcinoma; B-RAF; neoplasm metastasis; vascular endothelial growth factor; BRAF MUTATION; CLINICAL-IMPLICATIONS; PROGNOSTIC-FACTORS; CANCER; SURVIVAL; OUTCOMES; EPIDEMIOLOGY; VEGF;
D O I
10.3760/cma.j.issn.0366-6999.20122032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background BRAF(v600E) mutation is correlated with local aggressive clinicopathological features in papillary thyroid carcinoma; yet the relationship between this genetic variation and distant papillary thyroid carcinoma metastasis was unclear. This study aimed to investigate whether BRAF(v600E) is predictive for distant metastasis in the Chinese population. Methods One hundred and seven patients with papillary thyroid carcinoma were enrolled in this study, including 43 patients with distant metastasis and 64 patients without. Quantitative real-time polymerase chain reaction was used to detect BRAF(v600E) mutation, while immunohistochemistry was performed to detect vascular endothelial growth factor (VEGF) expression. The associations between distant metastasis and BRAF(v600E) mutation, and VEGF expression as well as local clinicopathological factors were determined. Results A total of 28.6% of the patients in the distant metastasis group harbored BRAF(v600E) mutation, which was significantly lower than in the without distant metastasis group (68.8%, P < 0.001). BRAF(v600E) mutation was negatively correlated with positive VEGF expression (P=0.001). Furthermore, 52.2% of the patients with distant metastasis exhibited VEGF expression, compared with 25.0% of those without. Higher levels of VEGF expression were also observed in the distant metastasis group. Tumor size, extra-thyroid invasion, and BRAF(v600E) mutation were independent predictors for distant metastasis according to multivariate analysis (odds ratios were 2.8, 12.4, and 0.3; 95% C/ 1.483-5.334, and 2.950-52.407, 0.100-0.890; P=0.002, 0.001, and 0.030, respectively). BRAF(v600E) mutation was negatively correlated with distant metastasis in adult subgroup analysis (P=0.005) but was not an independent parameter. Conclusions BRAF(v600E) mutation is predictive for distant metastasis in papillary thyroid carcinoma but not positively. VEGF may be involved in the pathogenesis of distant metastasis.
引用
下载
收藏
页码:3013 / 3018
页数:6
相关论文
共 50 条
  • [41] The Presence of Typical "BRAFV600E-Like" Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation
    Turchini, John
    Sioson, Loretta
    Clarkson, Adele
    Sheen, Amy
    Delbridge, Leigh
    Glover, Anthony
    Sywak, Mark
    Sidhu, Stan
    Gill, Anthony J.
    ENDOCRINE PATHOLOGY, 2023, 34 (01) : 112 - 118
  • [42] BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
    Su-jin Kim
    Kyu Eun Lee
    Jun Pyo Myong
    Jeong-hwan Park
    Yoon Kyung Jeon
    Hye Sook Min
    So Yeon Park
    Kyeong Cheon Jung
    Do Hoon Koo
    Yeo-Kyu Youn
    World Journal of Surgery, 2012, 36 : 310 - 317
  • [43] Histopathologic Characteristics of Thyroid Tumors Positive for BRAFV600E Mutation
    Nugent, W.
    Coyne, C.
    Nikiforova, M. N.
    Nikiforov, Y. E.
    MODERN PATHOLOGY, 2012, 25 : 148A - 149A
  • [44] Prohibitin Is Overexpressed in Papillary Thyroid Carcinomas Bearing the BRAFV600E Mutation
    Franzoni, Alessandra
    Dima, Mariavittoria
    D'Agostino, Maria
    Puppin, Cinzia
    Fabbro, Dora
    Di Loreto, Carla
    Pandolfi, Maura
    Puxeddu, Efisio
    Moretti, Sonia
    Celano, Marilena
    Bruno, Rocco
    Filetti, Sebastiano
    Russo, Diego
    Damante, Giuseppe
    THYROID, 2009, 19 (03) : 247 - 255
  • [45] BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
    Kim, Su-jin
    Lee, Kyu Eun
    Myong, Jun Pyo
    Park, Jeong-hwan
    Jeon, Yoon Kyung
    Min, Hye Sook
    Park, So Yeon
    Jung, Kyeong Cheon
    Koo, Do Hoon
    Youn, Yeo-Kyu
    WORLD JOURNAL OF SURGERY, 2012, 36 (02) : 310 - 317
  • [46] The prognostic significance of the BRAFV600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry
    McKelvie, Penelope A.
    Chan, Fiona
    Yu, Yong
    Waring, Paul
    Gresshoff, Irma
    Farrell, Stephen
    Williams, Richard A.
    PATHOLOGY, 2013, 45 (07) : 637 - 644
  • [47] BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis
    Li, Fei
    Chen, Guangqi
    Sheng, Chunjun
    Gusdon, Aaron M.
    Huang, Yueye
    Lv, Zhongwei
    Xu, Huixiong
    Xing, Mingzhao
    Qu, Shen
    ENDOCRINE-RELATED CANCER, 2015, 22 (02) : 159 - 168
  • [48] Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma
    Liang Guo
    Ya-qi Ma
    Yao Yao
    Meng Wu
    Zi-hui Deng
    Feng-wei Zhu
    Yu-kun Luo
    Jie Tang
    Scientific Reports, 9
  • [49] Morphological features predictive for BRAFV600E mutation in papillary thyroid microcarcinomas
    Nechifor-Boila, Adela Corina
    Szasz, Emoke-Andrea
    Descotes, Francoise
    Berger, Nicole
    Zahan, Ancuta Elena
    Loghin, Andrada
    Ceteras, Delia Maria
    Borda, Angela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (03): : 747 - 753
  • [50] Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma
    Guo, Liang
    Ma, Ya-qi
    Yao, Yao
    Wu, Meng
    Deng, Zi-hui
    Zhu, Feng-wei
    Luo, Yu-kun
    Tang, Jie
    SCIENTIFIC REPORTS, 2019, 9 (1)